Lv3
390 积分 2025-01-03 加入
Liver fibrosis marker is a potential predictor of the development of Fontan-associated liver diseases
7天前
已关闭
Cryobiopsy and dye marking guided by electromagnetic navigation bronchoscopy before resection of pulmonary nodule
14天前
已完结
Reduction in the need for surgery and mortality after early administration of fibrinolytics following empyema drainage
1个月前
已关闭
Oesophageal cancer
1个月前
已完结
Doublet chemotherapy, triplet chemotherapy, or doublet chemotherapy combined with radiotherapy as neoadjuvant treatment for locally advanced oesophageal cancer (JCOG1109 NExT): a randomised, controlled, open-label, phase 3 trial
1个月前
已完结
The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide
1个月前
已完结
Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus
2个月前
已完结
Neoadjuvant Chemoradiotherapy Combined with Atezolizumab for Resectable Esophageal Adenocarcinoma: A Single-arm Phase II Feasibility Trial (PERFECT)
2个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
2个月前
已完结
Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)
2个月前
已完结
皖公网安备34019202002308
